Kingdon Capital Management, L.L.C. Exelixis, Inc. Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $6.55 Million - $7.92 Million	-352,659 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $2.35 Million - $3.38 Million	106,140 Added 43.06%	352,659 $7.81 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $5.97 Million - $7.62 Million	246,519	246,519 $7.49 Million

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.